Biodegradable gelatin-based nanospheres as pH-responsive drug delivery systems
Source abstract
Abstract
Native gelatin, N,N'-ethylenebisacrylamide, and sodium methacrylate were inserted into a spherical crosslinked structure by a solvent-free emulsion polymerization method, in which sunflower seed oil containing different amounts of lecithin was selected as continuous phase. Nanogels were characterized by morphological analysis, particle size distribution, and determination of swelling degree. Different dimensional distributions (100-500 nm) and water affinities were obtained by varying the amount of surfactant in the polymerization feed. Nanogels were non-toxic on human bone marrow mesenchymal stromal cells and enzymatically stable in the gastric tract, with weight losses ranging from 58 to 20 % in pancreatin solution. Release profiles of diclofenac sodium salt from the nanogels were evaluated at different pH and found to depend on crosslinking degree and drug-polymer interactions; while in pancreatin solution, a complete release of the drug was observed. The release mechanism and the diffusional contribution were evaluated by semiempirical equations.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Surfactants and Colloidal Systems · Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Asif M, Arayne MS, Sultana N, Hussain F (2006) Fabrication of nanoparticles within polymeric pores for controlled release of drug. Pak J Pharm Sci 19:73–84
2. Carson J, Notis WM, Orris ES (1990) Colonic ulceration and bleeding during diclofenac therapy (I). N Engl J Med 323:13510.1056/NEJM199010043231422 ↗
3. Cascone MG, Lazzeri L, Carmignani C, Zhu ZH (2002) Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci Mater M 13:523–52610.1023/A:1014791327253 ↗
4. Cirillo G, Kraemer K, Fuessel S, Puoci F, Curcio M, Spizzirri UG, Altimari I, Iemma F (2010) Biological activity of a gallic acid-gelatin conjugate. Biomacromolecules 11:3309–331510.1021/bm100760x ↗
5. Colombo P, Bettini R, Santi P, Peppas NA (2000) Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today 3:198–20410.1016/S1461-5347(00)00269-8 ↗
6. Curcio M, Puoci F, Spizzirri UG, Iemma F, Cirillo G, Parisi OI, Picci N (2010a) Negative thermo-responsive microspheres based on hydrolyzed gelatin as drug delivery device. AAPS PharmSciTech 11:652–66210.1208/s12249-010-9429-5 ↗
7. Curcio M, Spizzirri UG, Iemma F, Puoci F, Cirillo G, Parisi OI, Picci N (2010b) Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release. Eur J Pharm Biopharm 76:48–5510.1016/j.ejpb.2010.05.008 ↗
8. d’Emanuele A, Dinarvand R (1995) Preparation, characterization, and drug release from thermoresponsive microspheres. Int J Pharm 118:237–24210.1016/0378-5173(94)00384-H ↗
9. Devi N, Maji TK (2010) Microencapsulation of isoniazid in genipin-crosslinked gelatin-A–k-carrageenan polyelectrolyte complex. Drug Dev Ind Pharm 36:56–6310.3109/03639040903061355 ↗
10. Dunne M, Corrigan OI, Ramtoola Z (2000) Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21:1659–166810.1016/S0142-9612(00)00040-5 ↗
11. Dutta RK, Sahu S (2012) Development of diclofenac sodium loaded magnetic nanocarriers of pectin interacted with chitosan for targeted and sustained drug delivery. Colloids Surf B Biointerfaces 97:19–2610.1016/j.colsurfb.2012.04.030 ↗
12. El-Mahdy M, Ibrahim ES, Safwat S, El-Sayed A, Ohshima H, Makino K, Muramatsu N, Kondo T (1998) Effects of preparation conditions on the monodispersity of albumin microspheres. J Microencapsul 5:661–67310.3109/02652049809008248 ↗
13. Friess W (1998) Collagen-biomaterial for drug delivery- review article. Eur J Pharm Biopharm 45:113–13410.1016/S0939-6411(98)00017-4 ↗
14. Gonçalves C, Pereira P, Gama M (2010) Self-assembled hydrogel nanoparticles for drug delivery applications. Materials 3:1420–146010.3390/ma3021420 ↗
15. Göpferich A (1996) Mechanism of polymer degradation and erosion. Biomaterials 17:103–11410.1016/0142-9612(96)85755-3 ↗
16. Hamidi M, Azadi A, Rafiei P (2006) Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 60:1638–164910.1016/j.addr.2008.08.002 ↗
17. Hopfenberg HB, Hsu KC (1978) Swelling-controlled, constant rate delivery systems. Polym Eng Sci 18:1186–119110.1002/pen.760181511 ↗
18. Iwanaga K, Yabuta T, Kakemi M, Morimoto K, Tabata Y, Ikada Y (2003) Usefulness of microspheres composed of gelatin with various cross-linking density. J Microencapsul 20:767–77610.1080/02652040310001600523 ↗
19. Li BZ, Wang LJ, Li D, Bhandari B, Li SJ, Lan Y, Chen XD, Mao ZH (2009) Fabrication of starch-based microparticles by an emulsification crosslinking method. J Food Eng 92:250–25410.1016/j.jfoodeng.2008.08.011 ↗
20. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Self-assembled hydrogel nanoparticles for drug delivery applications. Adv Drug Deliv Rev 60:1650–166210.1016/j.addr.2008.09.001 ↗
21. Mano JF (2008) Stimuli-responsive polymeric systems for biomedical applications. Adv Eng Mater 10:515–52710.1002/adem.200700355 ↗
22. May JE, Morse HR, Xu J, Donaldson C (2012) Development of a novel, physiologically relevant cytotoxicity model: application to the study of chemotherapeutic damage to mesenchymal stromal cells. Toxicol Appl Pharmacol 263:374–38910.1016/j.taap.2012.07.013 ↗
23. Park JH, Ye M, Park K (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10:146–16110.3390/10010146 ↗
24. Peniche C, Fernandez M, Gallardo A, Lopez-Bravo A, San Roman J (2003) Systems based on porous chitosan/polyacrylic acid microspheres. Macromol Biosci 3:540–54510.1002/mabi.200350023 ↗
25. Peppas NA, Sahlin JJ (1989) A simple equation for the description of solute release III. Coupling of diffusion and relaxation. Int J Pharm 57:169–17210.1016/0378-5173(89)90306-2 ↗
26. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–14710.1126/science.284.5411.143 ↗
27. Ritger PL, Peppas NA (1987) A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 5:23–3610.1016/0168-3659(87)90034-4 ↗
28. Sahiner N, Singh M (2007) In situ micro/nano-hydrogel synthesis from acrylamide derivates with lecithin organogel system. Polymer 48:2827–283410.1016/j.polymer.2007.01.005 ↗
29. Sairam M, Babu VR, Naidu BVK, Aminabhavi TM (2006) Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles. Int J Pharm 320:131–13610.1016/j.ijpharm.2006.05.001 ↗
30. Schwall CT, Banerjee IA (2009) Micro- and nanoscale hydrogel system for drug delivery and tissue engineering. Materials 2:577–61210.3390/ma2020577 ↗
31. Spizzirri UG, Parisi OI, Iemma F, Cirillo G, Puoci F, Curcio M, Picci N (2010) Antioxidant-polysaccharide conjugates for food application by eco-friendly grafting procedure. Carbohydr Polym 79:333–34010.1016/j.carbpol.2009.08.010 ↗
32. Spizzirri UG, Iemma F, Altimari I, Curcio M, Puoci F, Picci N (2012) Grafted gelatin microspheres as potential pH-responsive devices. J Mater Sci 47:3648–365710.1007/s10853-011-6211-3 ↗
33. Warner TD, Vojnovic I, Bishop-Bailey D, Mitchell JA (2006) Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. FASEB J 20:542–54410.1096/fj.05-4434fje ↗
34. Zhang H, Gao S (2007) Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro. Int J Pharm 329:122–12810.1016/j.ijpharm.2006.08.027 ↗